This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
This contract award is for the delivery of Doxorubicin Liposome 50mg/25ml vials to the U.S. Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,500.00 contract has a firm fixed price and an ultimate completion date of February 12, 2024. This is a delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
This federal contract award is for the delivery of DOXIL 50 MG/25 ML VIAL 25ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract has a firm fixed price of $20,383.96 and a completion date of January 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Doxil 50 mg/25 ml vials. The order has a potential value of $3,051.42 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution...
This federal contract award is a delivery order with a firm fixed price of $21,501.64 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is not set aside and has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA, which provides a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,633.80 firm fixed-price delivery order is for the supply of Doxil 50 mg/25 ml vials, with a completion date of December 30, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the U.S. Department of...
This federal contract award is a delivery order with a firm fixed price of $2,594.95 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has no set-aside designation, was made by the Defense Logistics Agency (DLA) to support medical supply chain requirements for the U.S. Department of Defense. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order with a firm fixed price of $2,664.30, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of June 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally....